Paeonol promotes arylamine N-acetyltransferase activity in rat liver tumour cells

Cytobios

Volumn 1998, Issue 379, 1998, Pages 99-110

  Chang, Huei Ling ^a   Chung, Jing Gung ^a   Ho, Chin Chin ^b   Hung, Chi Fu ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b JEN AI HOSPITAL   (Taiwan)

Author keywords

2 aminofluorene; N acetyl 2 aminofluorene; N acetyl p aminobenzoic acid; N acetyltransferase; p aminobenzoic acid; Paeonol

Indexed keywords

EID: 0009972494     PISSN: 00114529     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. ANDRES H. H., Kolb H. J. and Weiss L. 1983. Purification and physical-chemical properties of acetyl-CoA: arylamine N-acetyltransferase from pigeon liver. Biochim. biophys. Acta 746 182-92.
2. BRADFORD M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analyt. Biochem. 72 248-254.
3. CARTWRIGHT R. A., Glasham R. W., Rogers H. J., Ahmed R. A., Barham-Hall D., Higgens E. and Kahn M. A. 1982. Role of N-acetyltransferase phenotype in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2 842-6.
4. S slow acetylator congenic mice. Drug Metab. Dispos. 21 1057-63.
5. CHUNG J. G., Kuo H. H., Lin T. H., Ho C. C., Lee J. H., Lai J. M., Lev G. N. and Weber W. W. 1996. Evidence for arylamine N-acetyltransferase in the nematode Anisakis simplex. Cancer Letters 106 1-8.
6. CHUNG J. G., Wang H. H., Tsou M. F., Hsieh S. E., Lo H. H., Yen Y. S., Chang S. S., Wu L. T., Lee J. H. and Hung C. F. 1997a. Evidence for arylamine N-acetyltransferase activity in the bacterium Helicobacter pylori. Toxicol. Letters 91 63-71.
7. CHUNG J. G., Lee J. H., Ho C. C., Lai J. M., Chou Y. C., Teng H. H., Hung C. F. and Huangm S. C. 1997b. A survey of arylamine N-acetyltransferase activity in common fruits and vegetables. J. Food Biochem. 20 481-90.
8. CLELAND W. W. 1967. The statistical analysis of enzyme kinetics data. Adv. Enzymol. 29 1-32.
9. DEGUCHI T., Sakamoto Y., Sasaki S. and Uyemura K. 1988. Arylamine N-acetyltransferase from chicken liver. I. Monoclonal antibodies, immunoaffinity purification, and amino acid sequences. J. biol. Chem. 263 7528-33.
10. EINISTO P., Watanabe M., Ishidate M. and Nohmi T. 1991. Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutat. Res. 259 95-102.
11. FANG S. H., Chung J. G., Chang W. W. and Chang S. H. 1997. Candida albicans arylamineacetyltransferase: kinetics and characterization. Toxicol. Letters 92 109-16.
12. GRANT D. M., Blum M., Beer M. and Meyer U. A. 1991. Monomorphic and polymorphic human arylamine N-acetyltransferase: a comparison of liver isozymes and expressed products of two cloned genes. Mol. Pharmacol. 9 184-91.
13. HEIN D. W., Smolen T. N., Fox R. R. and Weber W. W. 1982a. Identification of genetically homozygous rapid and slow acetylators of drugs and environmental carcinogens among established inbred rabbit strains. J. Pharmacol. Exp. Ther. 223 40-4.
14. HEIN D. W., Omichinski J. G., Brewer D. W. and Weber W. W. 1982b. A unique pharmacogenetic expression of the N-acetylation polymorphism in the inbred hamster. J. Pharmacol. Exp. Ther. 220 8-15.
15. HEIN D. W. 1988 Acetylator genotype and arylamine-induced carcinogenesis. Biochim. biophys. Acta 948 37-66.
16. HEIN D. W., Rustan J. D., Bucher K. D., Furman E. J. and Martin W. J. 1991. Extrahepatic expression of the N-acetylation polymorphism toward arylamine carcinogens in tumor target organs of an inbred rat model. J. Pharmacol. Exp. Ther. 258 232-6.
17. ILETT K. F., David B. M., Detchon P., Castledon W. M. and Kwa R. 1987. Acetylator phenotype in colorectal carcinoma. Cancer Res. 47 1466-9.
18. LOWER G. M. 1982. Concepts in causality: chemically induced human urinary bladder cancer. Cancer 49 1056-66.
19. MINCHIN R. F., Reeves P. T., Teitel C. H., McManus M. E., Mojarrabi T., Ilett K. F. and Kadlubar F. F. 1992. N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem. biophys. Res. Commun. 185 839-44.
20. OHSAKO S. and Deguchi T. 1990. Cloning and expression of cDNAs for polymorphic and monomorphic N-acetyltransferase from human liver. J. biol. Chem. 265 4630-4.
21. ROBERT-THOMSON I. C., Ryan P., Khoo K. K., Hart W. J., McMichael A. J. and Burtler R. N. 1996. Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 347 1372-4.
22. TANG J. R. and Shi L. 1991. The inhibitory effects of sodium paeonol sulfate on calcium influx in the cultured neonatal rat heart cells. Acta Pharm. Sinica 26 161-5.
23. VATSIS K. P. and Weber W. W. 1993. Structural heterogeneity of Caucasian N-acetyltransferase at the NAT1 gene locus. Arch. Biochem. Biophys. 301 71-6.
24. 69 residue in the catalytic mechanism of N-hydroxylamine O-acetyltranslerase of Salmonella typhimurium: sequence similarity at the amino acid level suggests a common catalytic mechanism of acetyltransferase for S. typhimurium and higher organisms. J. biol. Chem. 267 8429-36.
25. WEBER W. W. and Hein D. W. 1985. N-acetylation pharmacogenetics. Pharmacol. Rev. 37 25-79.
26. WEBER W. W. 1987. The acetylator genes and drug response. Oxford University Press, New York, pp 21-55.
27. WHITAKER D. P. and Goosey M. W. 1993. Purification and properties of the enzyme arylamine N-acetyltransferase from the housefly Musca domestica. Biochem. J. 295 149-54.
28. YOSHIKAWA M., Uchida E., Kawaguchi A., Kitagawa I. A. and Yamahara J. 1992. Galloyloxypaeoniflorin, suffruticosides A, B, C, and paeonol glycoside, from Chinese moutan cortes. Chem. Pharm. Bull. 40 2248-50.